Search

everythinglearnresearchcommunity

for

Search:↓

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.

Personalized treatment plans are important for people with alopecia areata.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Vitiligo and alopecia areata may share common causes.

Alopecia areata negatively affects the self-esteem and quality of life of children and teens.

People with alopecia areata may have a higher risk of hearing loss.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

The monkey's hair loss was due to an autoimmune disease, not genetics.

A new CNN model can detect Alopecia Areata with 98% accuracy.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

New therapies for alopecia areata show potential but need more research.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Topical prostaglandin E2 can help treat both alopecia areata and vitiligo.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Betamethasone can effectively treat alopecia areata.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

Alopecia areata is an autoimmune hair loss condition linked to genetic factors.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Denosumab treatment for osteoporosis can cause hair loss.